Protective immunity induced by Bacillus anthracis toxin-deficient strains

Area of Science:

• * Infectious Diseases
• * Immunology
• * Microbial Pathogenesis

Background:

• * Bacillus anthracis secretes two toxins composed of protective antigen (PA), lethal factor (LF), and edema factor (EF).
• * Mutant strains deficient in one or more toxin components have been previously developed.
• * Understanding the immune response to these components is vital for anthrax vaccine development.

Purpose of the Study:

• * To investigate the antibody response to in vivo production of PA, LF, and EF in mice.
• * To assess the immunoprotective effects of different B. anthracis mutant strains.
• * To explore the role of humoral and non-humoral immune mechanisms in anthrax protection.

Main Methods:

• * Immunization of mice with spores of B. anthracis mutant strains lacking specific toxin components.
• * Measurement of antibody titers against PA, LF, and EF.
• * Evaluation of protection against a lethal anthrax challenge.

Main Results:

• * High antibody titers to PA were observed in mice immunized with PA-producing strains.
• * Antibody responses to EF and LF were weaker when produced alone but increased when co-produced with PA.
• * PA-deficient strains offered partial protection, suggesting non-humoral immune involvement. A control strain lacking the toxin plasmid provided no protection or antibody response.

Conclusions:

• * PA is the primary protective antigen, but LF and EF significantly contribute to immunoprotection.
• * Immune mechanisms beyond humoral response play a role in anthrax immunity.
• * The pXO1 plasmid may be essential for B. anthracis survival in a host, potentially through immune evasion.